ITULAZAX(®) versus Alutard SQ(®) in the treatment of allergic rhinitis induced by pollen from the birch homologous group: A cost‐minimization modeling analysis from the Danish societal perspective

BACKGROUND AND AIMS: Allergic rhinitis (AR) is an inflammatory disorder triggered by an allergic immune response to inhaled allergens. Birch pollen is the major allergenic tree pollen in parts of Europe. ITULAZAX® is a sublingual immunotherapy tablet for the treatment of adults with moderate‐to‐seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Rønborg, Steen M., Grand, Tobias Sydendal, Brandi, Henrik, Pollock, Richard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631325/
https://www.ncbi.nlm.nih.gov/pubmed/36434741
http://dx.doi.org/10.1002/clt2.12196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631325/
https://www.ncbi.nlm.nih.gov/pubmed/36434741
http://dx.doi.org/10.1002/clt2.12196

Ejemplares similares